Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
暂无分享,去创建一个
Jiesheng Kang | D. Rampe | D Rampe | J Kang | X L Chen | L Wang | L. Wang | J. Kang | X. Chen | Xiao‐Liang Chen | Lin Wang
[1] D. Rampe,et al. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. , 1998, The Journal of pharmacology and experimental therapeutics.
[2] K. Murray,et al. Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels. , 2000, The Journal of pharmacology and experimental therapeutics.
[3] N. White,et al. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. , 1993, British journal of clinical pharmacology.
[4] G. Billman,et al. Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I(Ks), in canine models of malignant ischemic ventricular arrhythmia. , 1999, Circulation.
[5] C. January,et al. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride. , 1997, The American journal of physiology.
[6] N. White,et al. Clinical Pharmacokinetics of Mefloquine , 1990, Clinical pharmacokinetics.
[7] P. Bennett,et al. Modulation of HERG potassium channels by extracellular magnesium and quinidine. , 1999, Journal of cardiovascular pharmacology.
[8] J. Papp,et al. Pharmacological block of the slow component of the outward delayed rectifier current (IKs) fails to lengthen rabbit ventricular muscle QTc and action potential duration , 2001, British journal of pharmacology.
[9] M. Keating,et al. MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.
[10] G. Edwards,et al. Potentiation of halofantrine‐induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine , 2001, British journal of pharmacology.
[11] E. Green,et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.
[12] G. Lefèvre,et al. Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers , 2000, European Journal of Clinical Pharmacology.
[13] P. Rosenthal,et al. Drug overdoses with antimalarial agents: prescribing and dispensing errors. , 1998, Journal of the American Medical Association (JAMA).
[14] A. Brown,et al. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG , 1997, FEBS letters.
[15] F. Ajayi,et al. ECG pharmacodynamics and pharmacokinetics of halofantrine and mefloquine , 1996 .
[16] S Nattel,et al. Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes. , 1998, Cardiovascular research.
[17] D. Roden,et al. Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone. , 1991, Circulation research.
[18] P. Coumel,et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome , 1997, Nature Genetics.
[19] A. Brown,et al. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. , 1996, Circulation.
[20] D. Rampe,et al. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide. , 2000, European journal of pharmacology.
[21] Jacques Barhanin,et al. KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.
[22] R. Hauer,et al. Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management , 2022 .
[23] J. Kopferschmitt,et al. Clinical Features and Management of Poisoning due to Antimalarial Drugs , 1987, Medical toxicology and adverse drug experience.
[24] R. N. Brogden,et al. Mefloquine , 1993, Drugs.
[25] D. Kyle,et al. Cardiac effects of antimalarial treatment with halofantrine , 1993, The Lancet.
[26] C. January,et al. Block of HERG Potassium Channels by the Antihistamine Astemizole and its Metabolites Desmethylastemizole and Norastemizole , 1999, Journal of cardiovascular electrophysiology.
[27] P. Waller,et al. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial. , 1997, British Journal of Clinical Pharmacology.
[28] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[29] M. Sanguinetti,et al. Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel , 1996, Nature.